The Path To Tarlatamab Approval: Leveraging Innovative Strategies and Global Regulatory Pathways
Crossref DOI link: https://doi.org/10.1007/s43441-025-00809-8
Published Online: 2025-05-26
Published Print: 2025-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pathak, Vandana
Pimentel, Claudia Arredondo
Cooney, Elli
Abbott, Brian
Kline, Jacqueline M.
Text and Data Mining valid from 2025-05-26
Version of Record valid from 2025-05-26
Article History
Received: 21 February 2025
Accepted: 20 May 2025
First Online: 26 May 2025
Declarations
:
: The authors declare no competing interests.